To reduce time spent on serial submissions and iterative reviewing, BMC Medicine offers to consider manuscripts on the basis of reviews received at other journals. We also support transfers of reviews obtained at BMC Medicine to other journals, including those outside of BMC and Springer Nature. Learn more from our Portable Reviews page.
We are pleased to announce the launch of our new article collection seeking submissions on all novel, impactful advances of irritable bowel syndrome, including disease burden, etiology, pathophysiology, and therapies.
BMC Medicine and BMC Cancer are welcoming submissions to a new joint collection on cancer targeted therapies. We are seeking manuscripts on all aspects of molecular targeted therapies, including novel therapies, treatment resistance, combination therapies and biomarker discovery.
Research: Apoptosis proteins as biomarkers and potential targeted therapy targets for thymic cancers
In this study, the authors demonstrated the relevance of pro-survival BCL-2 family of proteins as prognostic biomarkers and major drivers of thymomas and thymic carcinomas in patient samples and cell lines. The results suggest the use of BH3 mimetics such as Venetoclax (used in hematological cancers) as potential treatments.
Medication review is a core aspect of medicine optimization; a systematic review identified key medication review components, using this to inform the design of an improved review model for the standardized delivery of structured reviews. This has the potential for use by all healthcare professionals, with flexibility of use across a variety of healthcare settings.
The Editors of BMC Medicine are delighted to share with you a selection of key papers that highlight breast cancer research published in the journal to mark Breast Cancer Awareness Month 2021.
In this Q & A, we interviewed Matthew Quaife and Shuai Li and discuss their first-hand perspectives as recent members of the editorial board scheme for BMC Medicine.
BMC Medicine is recruiting new Editorial Board Members. To increase our engagement with the Editorial Board and community at large, we are recruiting Editorial Board Members to be part of a collaborative editorial model whereby Editorial Board Members assess manuscripts in their area of expertise alongside the in-house Editorial team. To apply, click here.
Highlight: Portable Peer-Review
Supporting SDG3: Good Health and Well-Being
BMC Medicine is committed to playing a role in advancing progress towards achieving the Sustainable Development Goals (SDGs), including SDG3, by supporting researchers in disseminating their related work and showcasing this to assist policy-makers, governments and humanitarian organizations in making research-backed decisions to advance the international well-being agenda. Read more here.
Congratulations to Professor Min Li as APA elect for 2022
We would like to congratulate Min Li, Professor of Medicine, Surgery and Cell Biology at the University of Oklahoma Health Sciences Center in the USA, for being elected as the president of the American Pancreatic Association in 2022. Professor Li is an active researcher in the field of pancreatic cancer and is a valuable member in the oncology section of the editorial advisory board for BMC Medicine.
Aims and scope
BMC Medicine is the flagship medical journal of the BMC series. An open access, transparent peer-reviewed general medical journal, BMC Medicine publishes outstanding and influential research in all areas of clinical practice, translational medicine, medical and health advances, public health, global health, policy, and general topics of interest to the biomedical and sociomedical professional communities. We also publish stimulating debates and reviews as well as unique forum articles and concise tutorials.
5mC regulator-mediated molecular subtypes depict the hallmarks of the tumor microenvironment and guide precision medicine in bladder cancer
Most accessed (recent)
Correspondence article | 19 August 2020
Considerations for target oxygen saturation in COVID-19 patients: are we under-shooting?
Niraj Shenoy et al.
Correspondence article | 15 July 2020
New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis
Yuan Hou et al.
Opinion article | 15 July 2020
Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic
Ioannis Kyrou et al.
Editorial | 14 July 2020
Systems all the way down: embracing complexity in mental health research
Eiko I. Fried and Donald J. Robinaugh
Research | 03 June 2020
Real-time monitoring the transmission potential of COVID-19 in Singapore, March 2020
Amna Tariq et al.
Research article | 07 May 2020
Quantifying the impact of physical distance measures on the transmission of COVID-19 in the UK
Christopher I. Jarvis et al.
Research article | 06 May 2020
A single-center, retrospective study of COVID-19 features in children: a descriptive investigation
Huijing Ma et al.
Source: Web of Science
Correspondence | 24 March 2010
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
Kenneth F Schulz, Douglas G Altman and David Moher
Debate | 14 May 2013
Toward the future of psychiatric diagnosis: the seven pillars of RDoC
Bruce N Cuthbert and Thomas R Insel
Research Article | 26 December 2006
Collagen reorganization at the tumor-stromal interface facilitates local invasion
Paolo P Provenzano, Kevin W Eliceiri, Jay M Campbell, David R Inman, John G White and Patricia J Keely
Research Article | 24 June 2008
miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells
Joachim Silber, Daniel A Lim, Claudia Petritsch, Anders I Persson, Alika K Maunakea, Mamie Yu, Scott R Vandenberg, David G Ginzinger, C David James, Joseph F Costello, Gabriele Bergers, William A Weiss, Arturo Alvarez-Buylla and J Graeme Hodgson
Research Article | 26 July 2011
Cross-national epidemiology of DSM-IV major depressive episode
Evelyn Bromet, Laura Helena Andrade, Irving Hwang, Nancy A Sampson, Jordi Alonso, Giovanni de Girolamo, Ron de Graaf, Koen Demyttenaere, Chiyi Hu, Noboru Iwata, Aimee N Karam, Jagdish Kaur, Stanislav Kostyuchenko, Jean-Pierre Lépine, Daphna Levinson, Herbert Matschinger, Maria Elena Medina Mora, Mark Oakley Browne, Jose Posada-Villa, Maria Carmen Viana, David R Williams and Ronald C Kessler
Source: Web of Science
Call for papers
Targeted Therapies for Cancer
The joint BMC Medicine and BMC Cancer collection will remain open and accept submissions for one year after launch.
Taking on the challenge: Food sensitivity, intolerance and altered microbiota in irritable bowel syndrome
The collection will remain open and accept submissions for one year after launch.
Diabetic Kidney Disease: Advances in Disease Burden, Etiology, Pathophysiology, and Therapies
The collection will remain open and accept submissions until June 2022.
Global Outbreaks and Responses
Guest editors: Professor Dale Fisher, Dr. Gail Carson, and Dr. Lina Moses.
New Frontiers in Diagnosis, Treatment and Management of Neuromuscular Disorders
Guest editor: Bradley Turner
Non-malarial febrile illness
Guest editor: Philippe Guerin
Complexity in Mental Health Research: Theory, Method, and Empirical Contributions
Guest editors: Dr Eiko I. Fried and Dr Donald Robinaugh
Cardiovascular Issues in Underrepresented Populations
Guest editors: Prof Deborah Lawlor, Prof Naveed Sattar and Prof Aletta E Schutte
Who dies of what? Strengthening CRVS systems in the Sustainable Development Goals era
Guest editor: Alan D. Lopez
Stunting, undernutrition and obesity: the triple threat of childhood malnutrition
Guest editors: Prof. Andrew Prentice and Dr. Martha Mwangome
See all article collections here.
Top altmetric articles
Nature Communitites: Behind the Paper
We are now collaborating with Nature Communities, allowing authors to share experiences designing the study and collecting data by writing their own blog-style post on the paper.
Read the latest Behind the Paper article here:
Obesity-related colorectal cancer risk differs for men and women
Reviews and comments
Sign up to receive article alerts
BMC Medicine is published continuously online-only. We encourage you to sign up to receive free email alerts to keep up to date with all of the latest articles by registering here.
From the blog
08 October 2021
23 September 2021
14 July 2021
- Editorial Team
- Editorial Board
- Call for papers
- Editor’s choice
- Sign up for article alerts and news from this journal
Annual Journal Metrics
45 days to first decision for reviewed manuscripts only
9 days to first decision for all manuscripts
108 days from submission to acceptance
42 days from acceptance to publication
13,236 Altmetric mentions
BMC Medicine is happy to consider manuscripts that have been, or will be, posted on a preprint server. Authors are able to submit their manuscripts directly from medRxiv, without having to re-upload files.
BMC Medicine is accepting Registered Reports. Find out more about this innovative format in our Submission Guidelines.